ScholarIQanswers from OpenAlex & ORCID
Jane Matthews
ResearcherPublications, citations & collaboration network
Jane Matthews is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jane Matthews have?
ScholarIQindexed works
Jane Matthews has 219 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jane Matthews have?
ScholarIQcitation count
Jane Matthews has 7,709 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jane Matthews?
ScholarIQh-index
Jane Matthews has an h-index of 47 in OpenAlex.
What is the i10-index of Jane Matthews?
ScholarIQi10-index
Jane Matthews has an i10-index of 119 in OpenAlex.
What is the ORCID of Jane Matthews?
ScholarIQorcid
The ORCID for Jane Matthews is on the source record.
What is the OpenAlex record for Jane Matthews?
ScholarIQopenalex
The OpenAlex for Jane Matthews is on the source record.
What are the most-cited papers on Jane Matthews?
ScholarIQmost cited works
Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non–Small-Cell Lung Cancer
Michael P. Mac Manus, Rodney J. Hicks, Jane Matthews, Allan McKenzie, Danny Rischin, Eeva Salminen, David Ball
High rate of detection of unsuspected distant metastases by PET in apparent Stage III non–small-cell lung cancer: implications for radical radiation therapy
Michael P. Mac Manus, Rodney J. Hicks, Jane Matthews, Annette Hogg, Allan F McKenzie, Andrew Wirth, Robert E. Ware, David Ball
Randomized Trial of Coordinated Psychosocial Interventions Based on Patient Self-Assessments Versus Standard Care to Improve the Psychosocial Functioning of Patients With Cancer
Sue‐Anne McLachlan, Ann Allenby, Jane Matthews, Andrew Wirth, David W. Kissane, Michelle Bishop, J. Beresford, John Zalcberg
A benefits realization management building information modeling framework for asset owners
Peter E.D. Love, Jane Matthews, Ian R. Simpson, Andrew Hill, Oluwole Alfred Olatunji
(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.
Rodney J. Hicks, Victor Kalff, Michael MacManus, Robert E. Ware, Annette Hogg, Allan F McKenzie, Jane Matthews, David Ball